Relmada Therapeutics, Inc. (RLMD)

NASDAQ: RLMD · Real-Time Price · USD

6.65

+0.13 (1.99%)

At close: Jun 12, 2026, 4:00 PM EDT

6.78

+0.13 (1.95%)

After-hours: Jun 12, 2026, 5:15 PM EDT

Relmada Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	9.78	3.5	3.86	4.09	5.4	44.44
Short-Term Investments	224.19	89.51	41.05	92.23	142.93	167.47
Cash & Short-Term Investments	233.96	93.01	44.91	96.32	148.32	211.91
Cash Growth	764.58%	107.10%	-53.38%	-35.06%	-30.01%	80.98%
Other Receivables	-	-	-	-	0.51	0.09
Total Trade Receivables	-	-	-	-	0.51	0.09
Other Current Assets	1.38	0.98	0.89	1.19	4.04	11.3
Total Current Assets	235.34	93.98	45.8	97.51	152.87	223.3
Other Long-Term Assets	0.02	0.02	0.02	0.04	0.03	0.03
Total Assets	235.36	94	45.82	97.55	152.91	223.33
Accounts Payable	5.73	1.57	4.13	3.51	5.26	11.19
Accrued Expenses	7.16	4.86	6.16	8.69	7.21	3.87
Total Current Liabilities	12.89	6.43	10.29	12.19	12.47	15.06
Other Long-Term Liabilities	3.74	1.06	0	-	-	-
Total Long-Term Liabilities	3.74	1.06	0	-	-	-
Total Liabilities	16.63	7.49	10.3	12.19	12.47	15.06
Common Stock	0.1	0.07	0.03	0.03	0.03	0.03
Additional Paid-in Capital	935.95	784.71	676.37	646.23	602.52	513.3
Retained Earnings	-717.32	-698.27	-640.88	-560.9	-462.11	-305.07
Shareholders' Equity	218.73	86.51	35.52	85.36	140.44	208.27
Total Liabilities & Equity	235.36	94	45.82	97.55	152.91	223.33
Net Cash (Debt)	233.96	93.01	44.91	96.32	148.32	211.91
Net Cash Growth	151.56%	107.10%	-53.38%	-35.06%	-30.01%	80.98%
Net Cash Per Share	4.37	2.36	1.49	3.20	5.01	12.07
Book Value	218.73	86.51	35.52	85.36	140.44	208.27
Book Value Per Share	4.09	2.19	1.18	2.84	4.74	11.87
Tangible Book Value	218.73	86.51	35.52	85.36	140.44	208.27
Tangible Book Value Per Share	4.09	2.19	1.18	2.84	4.74	11.87

SEC Filings: 10-K · 10-Q